Skip to content

Analysis of the Prevalence and Influencing Factors of Metabolic Syndrome in Inpatients with Schizophrenia

Analysis of the Prevalence and Influencing Factors of Metabolic Syndrome in Inpatients with Schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123995
Enrollment
Unknown
Registered
2026-05-06
Start date
2026-06-10
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Non-patient group:None
Patient group:None

Sponsors

The Psychiatric Hospital of Zhongjiang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with schizophrenia who meet the diagnostic criteria for schizophrenia in the 10th Revision of the International Classification of Diseases (ICD - 10); 2.Patients with a hospital stay of at least 3 months.

Exclusion criteria

Exclusion criteria: 1.Patients with concurrent malignant tumors or those with significant organ dysfunction; 2.Patients who have a history of other mental disorders in the past or who currently have other coexisting mental disorders.

Design outcomes

Primary

MeasureTime frame
Types of antipsychotic drugs taken, dosage of the drugs, duration of medication, clinical symptoms, lipid and blood sugar test reports;Basic demographic information;Unhealthy living habits and exercise habits;Lipid metabolism indicators;Severity of the illness;anamnesis;Length of hospital stay and course of disease;body mass index;

Countries

China

Contacts

Public ContactYu Hongli

The Psychiatric Hospital of Zhongjiang

1421835342@qq.com+86 838 7101968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026